Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Dalian Medical UniversityActive in the last 2 years

Bing Qi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7723-8998; OpenAlex author ID A5030128184. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2020: 2 papers · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 4

  1. Prognostic and therapeutic value of the Eph/Ephrin signaling pathway in pancreatic cancer explored based on bioinformatics. Co-author DOI 10.1038/s41598-024-68385-9↗
  2. An immune-related lncRNA signature for the prognosis of pancreatic adenocarcinoma. Co-author DOI 10.18632/aging.203323↗
  3. The potential drug for treatment in pancreatic adenocarcinoma: a bioinformatical study based on distinct drug databases. Co-author DOI 10.1186/s13020-020-00309-x↗
  4. The nine ADAMs family members serve as potential biomarkers for immune infiltration in pancreatic adenocarcinoma. Co-author DOI 10.7717/peerj.9736↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Han Liu · 3 shared papers, 2020–2021 · strength 0.35
  2. Shilin Xia · 3 shared papers, 2020–2021 · strength 0.35
  3. Xueying Shi · 2 shared papers, 2020–2021 · strength 0.24
  4. Qihang Yuan · 1 shared paper, 2024 · strength 0.22
  5. Xu Chen · 1 shared paper, 2024 · strength 0.22
  6. Dong Shang · 1 shared paper, 2024 · strength 0.22
  7. Jifeng Liu · 1 shared paper, 2024 · strength 0.22
  8. Shuang Li · 1 shared paper, 2024 · strength 0.22
  9. Qi Zhou · 1 shared paper, 2021 · strength 0.13
  10. Ji Li · 1 shared paper, 2021 · strength 0.13
  11. Yajun Gu · 1 shared paper, 2021 · strength 0.13
  12. Fangyue Guo · 1 shared paper, 2020 · strength 0.11
  13. Lei Yao · 1 shared paper, 2020 · strength 0.11
  14. Yuan Yuan · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.